Pharma Consulting

Strategic advisory services helping pharmaceutical companies navigate market access, pricing strategy, health economics, and regulatory pathways to maximize product value and commercial success.

Behind-the-scenes

May 11, 2026

•

2 min read

I've quit pharma. Am I mad?

Why I left Gilead, what Von Hein Consulting does, and what doesn't change for this newsletter.

Mirko von Hein

Systematic Literature Review

Responsibility, Risk, and the Future of Evidence

Feb 7, 2026

•

4 min read

Responsibility, Risk, and the Future of Evidence

What building a HEOR consultancy during COVID reveals about leadership, judgment, and where our field is heading

Mirko von Hein

Pharma Consulting

I've quit pharma. Am I mad?

Responsibility, Risk, and the Future of Evidence

The HEOR Intel You Actually Need

Tracking what matters in HEOR, market access, and pharma consulting for your career success